4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-24-130272
Options or other derivatives
- Chief Executive Officer acquired 1,015,743 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gros David-Alexandre C · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +1,015,743 | 1,015,743 | D |
Loading xslF345X05/ownership.xml…